Illumina, Inc. (NASDAQ:ILMN) today announced that the Genome Institute of Singapore (GIS), a flagship institution of Singapore and one of the top research centers in the world, has purchased four additional Genome Analyzers taking its installed base to six. Among researchers at GIS, the Genome Analyzer continues to be the preferred platform for conducting sequencing […]
CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ:HLCS – News) today announced the shipment of a Helicos™ Genetic Analysis System to Stanford University for use in research. The unique ability of the Helicos Genetic Analysis System to obtain sequence information from individual DNA molecules couples unparalleled throughput and scalability with an unbiased view of DNA and RNA that […]
Recent recalls in the pharmaceutical industry have increased awareness of the need to improve contaminant and impurity analysis in drug manufacturing. Biopharmaceutical companies are responding to this challenge for products produced in cell culture to include in-process contaminant and impurity analysis for rapid detection of the smallest known self-replicating organism, called Mycoplasma. To assist in […]
Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis by becoming an Illumina Connect partner. Illumina Connect is a […]
Leaders in sequence informatics and desktop sequence analysis join forces to provide users with enhanced, interoperable sequence search, analysis and data management capabilities WESTBOROUGH, Mass.–GenomeQuest and Invitrogen today announced that the GenomeQuest™ 5.0 web-based sequence search, analysis and data management platform is now interoperable with Invitrogen’s Vector NTI Advance™ desktop sequence analysis solution. Ronald Ranauro, […]
454 Life Sciences Corporation, a Roche company, announced the launch of the new GS FLX Titanium series reagents and software that are transforming the life science’s industry. The new reagent kits provide individual sequencing reads with an improved Q20 length of 400 base pairs (99% accuracy at the 400th base and higher for preceding bases) […]
Applied Biosystems (NYSE:ABI) today announced a new genomic analysis platform, the SOLiD(TM) 3 System, that is expected to enable scientists to sequence a human genome for approximately $10,000. Significant cost-reduction and productivity enhancements have been built into the company’s latest ultra-high-throughput genomic analysis platform, enabling researchers to dramatically drive down the cost of sequencing entire […]
QIAGEN Acquires Biosystems Business from Biotage Venlo, The Netherland, October 1, 2008 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has acquired all assets related to the Biosystems business from Biotage AB, a publicly listed developer, manufacturer and distributor of products for genetic analysis and medicinal chemistry headquartered in Uppsala, […]
454 Life Sciences, a Roche company, and GenomeQuest, Inc. announced a co-marketing agreement whereby GenomeQuest will offer its recently launched On-Demand Informatics Service to users of the 454 Genome Sequencer FLX System. GenomeQuest’s high-throughput annotation and data management tools enable rapid characterization of all sequences generated by the Genome Sequencer FLX System. The combination of […]
454 Life Sciences, a Roche company, and Integrated DNA Technologies, Inc., Coralville, USA announced today they have entered into an exclusive co-promotional agreement wherein IDT will design, synthesize, and purify the fusion primers required for certain 454 Sequencing applications. These applications include ultra-deep amplicon sequencing for detection of low-frequency mutations in disease associated genes, and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
